Label updates include addition of two thumb flexor muscles and increased maximum cumulative dose DUBLIN, April 20, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT), which recently completed the ...
-- BOTOX® has demonstrated efficacy and has an established safety profile with over 10 years of clinical use in adult upper limb spasticity NORTH CHICAGO, Ill., July 29, 2021 /PRNewswire/ -- Allergan, ...
(RTTNews) - Allergan, an AbbVie (ABBV) company, said that the U.S. Food and Drug Administration has approved a label expansion of BOTOX to include eight new muscles for the treatment of upper limb ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback